Lannett Hit With Del. Suit Over Generic-Drug Price-Fixing

A Lannett Company Inc. shareholder filed a derivative suit Monday in Delaware federal court against former and current company officers in connection with an alleged industrywide generic-drug price-fixing scheme that has...

Already a subscriber? Click here to view full article